Literature DB >> 19883207

Hepatic maturation of human fetal hepatocytes in four-compartment three-dimensional perfusion culture.

Alexander Ring1, Jörg Gerlach, Grant Peters, Benjamin J Pazin, Crescenzio F Minervini, Morris E Turner, Robert L Thompson, Fabio Triolo, Bruno Gridelli, Toshio Miki.   

Abstract

Bio-artificial liver support systems have been utilized as bridging devices to support acute and chronic liver injury. However, prolonged function of adult hepatocytes has not been achieved due to compromised proliferation and long-term survival of adult cells in vitro. As an alternative cell source, we investigated the potential of human fetal hepatocytes (hFH) in a four-compartment hollow fiber-based three-dimensional (3D) perfusion culture system. hFH were isolated from 17- to 19-gestational-week livers and cultured in the 3D perfusion bioreactors for 14 days. Metabolism activity, hepatocyte-specific gene expression, protein expression, and hepatic function were investigated. Increased glucose consumption and lactate production indicated cell proliferation in the bioreactor. The ratio of cytochrome P450 3A4 to 3A7 gene expression and the increase of the number of asialoglycoprotein receptor-positive cells indicated cell differentiation into mature hepatocytes. Histological and immunohistochemical analysis revealed reorganization of fetal liver cells. Hepatic function was further examined for ammonia metabolism and for albumin production using colorimetric assays and enzyme-linked immunosorbent assay, respectively. In contrast to conventional 2D culture, the 3D perfusion culture system induced functional maturation to hFH; these cells may be useful as an alternative cell source for extracorporeal liver support.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19883207     DOI: 10.1089/ten.TEC.2009.0342

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.056


  8 in total

1.  Cell therapeutic options in liver diseases: cell types, medical devices and regulatory issues.

Authors:  Andreas K Nussler; Katrin Zeilinger; Lilianna Schyschka; Sabrina Ehnert; Jörg C Gerlach; Xueying Yan; Serene M L Lee; Maren Ilowski; Wolfgang E Thasler; Thomas S Weiss
Journal:  J Mater Sci Mater Med       Date:  2011-04-03       Impact factor: 3.896

Review 2.  Bioreactor technologies to support liver function in vitro.

Authors:  Mohammad R Ebrahimkhani; Jaclyn A Shepard Neiman; Micha Sam B Raredon; David J Hughes; Linda G Griffith
Journal:  Adv Drug Deliv Rev       Date:  2014-03-05       Impact factor: 15.470

3.  Induction of Hepatic and Endothelial Differentiation by Perfusion in a Three-Dimensional Cell Culture Model of Human Fetal Liver.

Authors:  Christopher Pekor; Jörg C Gerlach; Ian Nettleship; Eva Schmelzer
Journal:  Tissue Eng Part C Methods       Date:  2015-02-11       Impact factor: 3.056

Review 4.  New advances in MR-compatible bioartificial liver.

Authors:  Rex E Jeffries; Jeffrey M Macdonald
Journal:  NMR Biomed       Date:  2011-02-20       Impact factor: 4.044

Review 5.  Bioreactors addressing diabetes mellitus.

Authors:  Danielle M Minteer; Jorg C Gerlach; Kacey G Marra
Journal:  J Diabetes Sci Technol       Date:  2014-08-26

Review 6.  Wnt/catenin signaling in adult stem cell physiology and disease.

Authors:  Alexander Ring; Yong-Mi Kim; Michael Kahn
Journal:  Stem Cell Rev Rep       Date:  2014-08       Impact factor: 5.739

7.  Analysis of type II diabetes mellitus adipose-derived stem cells for tissue engineering applications.

Authors:  Danielle Marie Minteer; Matthew T Young; Yen-Chih Lin; Patrick J Over; J Peter Rubin; Jorg C Gerlach; Kacey G Marra
Journal:  J Tissue Eng       Date:  2015-04-02       Impact factor: 7.813

8.  Open-Porous Hydroxyapatite Scaffolds for Three-Dimensional Culture of Human Adult Liver Cells.

Authors:  Anthony Finoli; Eva Schmelzer; Patrick Over; Ian Nettleship; Joerg C Gerlach
Journal:  Biomed Res Int       Date:  2016-06-15       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.